Ranbaxy to launch Lipitor in US by November

PUBLISHED ON: September 8, 2011 | Duration: 2 min, 12 sec

   
loading..
Ranbaxy will launch the generic version of the world's top selling cholesterol-controlling drug Lipitor in the US markets in November. This opens up a big opportunity of around $500 million business for Ranbaxy, since it enjoys a six-month exclusivity period.
ALSO WATCH
Buy Sun Pharma For Long Term, Says TS Harihar

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................